Literature DB >> 11704795

Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.

L Hambach1, M Eder, E Dammann, K Battmer, A Stucki, G Heil, A Ganser, B Hertenstein.   

Abstract

We report a patient with Ph-positive CML who developed a Ph-negative AML in donor cells 14 months after BMT from an HLA-identical male unrelated donor. The Ph translocation could not be detected by either conventional cytogenetics, FISH or RT-PCR analysis excluding relapse of CML in myeloid blast crisis. Chimerism studies were performed by variable number of tandem repeats (VNTR) analysis. These revealed donor-type hematopoiesis in both unseparated mononuclear cells and CD34+ selected blasts proving the leukemia to be of donor origin. The patient received three cycles of polychemotherapy with mitoxantrone, topotecan and ara-c resulting in CR after the first treatment cycle and reconstitution with donor hematopoiesis. A second transplant from a female alternative matched unrelated donor was performed after conditioning with fludarabine and 200 cGy TBI and was well tolerated. Nine months after the second transplant the patient is at home and in CR. T cell chimerism was studied by sex chromosome analysis and revealed complete female donor chimerism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704795     DOI: 10.1038/sj.bmt.1703225

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

Review 1.  Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.

Authors:  H Shiozaki; K Yoshinaga; T Kondo; Y Imai; M Shiseki; N Mori; M Teramura; T Motoji
Journal:  Bone Marrow Transplant       Date:  2013-09-09       Impact factor: 5.483

Review 2.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

Review 3.  Risks and mechanisms of oncological disease following stem cell transplantation.

Authors:  Sergey V Anisimov; Asuka Morizane; Ana S Correia
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

4.  Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature.

Authors:  Komal Galani Deshmukh; Katalin Kelemen
Journal:  Life (Basel)       Date:  2022-04-08

5.  Volunteer unrelated donor cell-derived acute myeloid leukemia with RUNX1-RUNX1T1.

Authors:  Shinya Hagiwara; Shigeru Kusumoto; Asahi Ito; Ayako Masaki; Kazuhide Shiraga; Takuto Tachita; Kentaro Hirade; Kana Oiwa; Tomotaka Suzuki; Shiori Kinoshita; Masaki Ri; Yasuhiko Ito; Hirokazu Komatsu; Hiroshi Inagaki; Shinsuke Iida
Journal:  EJHaem       Date:  2021-02-09

Review 6.  Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review.

Authors:  Makoto Murata; Yuichi Ishikawa; Haruhiko Ohashi; Seitaro Terakura; Kazutaka Ozeki; Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-05-10       Impact factor: 2.490

7.  Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities.

Authors:  Matthew P Tilson; Richard J Jones; Amy Sexauer; C A Griffin; Laura A Morsberger; Denise A S Batista; Donald Small; Kathleen H Burns; Christopher D Gocke; Milena Vuica-Ross; Michael J Borowitz; Amy S Duffield
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-13       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.